Tag
Rossari Biotech Limited
5 articles
Rossari Biotech’s strong Q2 FY27 performance, highlighted by a record revenue of ₹698 crore—a 19% year-over-year increase—demonstrates continued momentum across its diverse business segments, including HPPC, Textile Specialty Chemicals, and Animal Health Nutrition. Bolstered by a 34% surge in export sales, the company’s strategic focus on margin improvement and working capital optimization is evident in its reduced net debt and improved working capital days. To further strengthen its regional presence and secure raw material access, Rossari Biotech’s board approved leasing land in Saudi Arabia for a greenfield manufacturing facility, signaling a commitment to international expansion and positioning the company for sustained growth.
Rossari Biotech Q2 FY27 Revenue Up 19% to Rs 698 Cr
Rossari Biotech reported its highest-ever quarterly revenue of Rs 698 crore, a 19% YoY growth, and EBITDA of Rs 87 crore, up 21% YoY for Q2 FY27.
The Board approved leasing land in Saudi Arabia for a
Rossari Biotech Q2 & H1 FY27 Earnings Call Recording Available
Rossari Biotech intimates availability of audio recording for its Q2 & H1 FY27 earnings conference call held on October 19, 2026.
The disclosure is made pursuant to SEBI Listing Regulations (Regulatio
Rossari Biotech Q2 Revenue Hits Record Rs 698 Crores
Rossari Biotech reported record Q2 FY27 revenue of Rs 697.6 crores, up 19.0% YoY, with EBITDA reaching Rs 87.0 crores, growing 20.9% YoY.
The company achieved highest-ever export sales of Rs 216.4 cro
Rossari Biotech Q2 Revenue Up 19% to ₹698 Crores
Rossari Biotech reported Q2FY27 consolidated revenue of ₹697.6 crores, a 19% YoY growth, with EBITDA up 20.9% to ₹87.0 crores.
Net working capital improved to 86 days and net debt reduced to ₹221 cror
Rossari Biotech Q2 PAT Rises 5.5% YoY
Board approved Q2 FY2026 standalone and consolidated unaudited financial results, reporting a consolidated PAT of ₹389.07 million.
Approved leasing of land in Saudi Arabia by wholly-owned subsidiary R